130 related articles for article (PubMed ID: 32386184)
1. High-mobility group box 3 (HMGB3) silencing inhibits non-small cell lung cancer development through regulating Wnt/β-catenin pathway.
Li Y; Ma Y; Zhang T; Feng C; Liu Y
Biol Chem; 2020 Sep; 401(10):1191-1198. PubMed ID: 32386184
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway.
Zhuang S; Yu X; Lu M; Li Y; Ding N; Ding Y
J Gynecol Oncol; 2020 Nov; 31(6):e91. PubMed ID: 33078596
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524
[TBL] [Abstract][Full Text] [Related]
4. CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1.
Liao Y; Feng J; Sun W; Wu C; Li J; Jing T; Liang Y; Qian Y; Liu W; Wang H
J Exp Clin Cancer Res; 2021 Aug; 40(1):275. PubMed ID: 34465343
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/β-catenin signaling.
Xie X; Pan J; Han X; Chen W
Chem Biol Interact; 2019 Feb; 300():73-81. PubMed ID: 30639441
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of HMGB3 expression in patients with non-small cell lung cancer.
Song N; Liu B; Wu JL; Zhang RF; Duan L; He WS; Zhang CM
Tumour Biol; 2013 Oct; 34(5):2599-603. PubMed ID: 23609034
[TBL] [Abstract][Full Text] [Related]
7. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Eur J Pharmacol; 2019 Nov; 862():172615. PubMed ID: 31422060
[TBL] [Abstract][Full Text] [Related]
9. TMED3 exerts a protumor function in non-small cell lung cancer by enhancing the Wnt/β-catenin pathway via regulation of AKT.
Zhang D; Sun L; Zhang J
Toxicol Appl Pharmacol; 2021 Dec; 433():115793. PubMed ID: 34758370
[TBL] [Abstract][Full Text] [Related]
10. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
11. HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/β-catenin pathway.
Zhang Z; Chang Y; Zhang J; Lu Y; Zheng L; Hu Y; Zhang F; Li X; Zhang W; Li X
PLoS One; 2017; 12(7):e0179741. PubMed ID: 28678825
[TBL] [Abstract][Full Text] [Related]
12. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
13. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
14. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
15. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
16. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
[TBL] [Abstract][Full Text] [Related]
17. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
Qi G; Li L
Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
[TBL] [Abstract][Full Text] [Related]
20. Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.
Wang T; Liu X; Tian Q; Liang T; Chang P
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):637-644. PubMed ID: 29461591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
